Nordicus Partners Corporation Engages FORCE Family Office
Beverly Hills, California., May 23, 2024 (GLOBE NEWSWIRE) — Nordicus Partners Corporation (OTCQB:NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic and U.S. Life Sciences companies with optimal conditions to establish themselves on the U.S. market, announced on the 15th of May, 2024 the acquisition of a 95% stake in Orocidin A/S (“Orocidin”) and announced today that it has engaged investor awareness specialists, FORCE Family Office (“FORCE”). Representing the world’s largest community of Family Offices, Foundations, and Endowments, FORCE will be sharing Nordicus’ and Orocidin’s story with this community in upcoming webinars along with other events and activities.
Related news for (NORD)
- Nordicus Partners Corporation Announces Key Milestone in Development of Orocidin’s Breakthrough Treatment for Periodontitis
- Nordicus Partners To Host Investor Relations Webinar on July 10, 2024
- Orocidin – New Insights Into The Treatment Of Periodontitis
- Nordicus Partners Corporation Appoints Peter Severin as Chairman Of The Board of Directors